Insulet expands Omnipod 5 to four more International markets
Insulet (PODD) announced its revolutionary Omnipod 5 Automated Insulin Delivery System is now available in Australia and will soon be offered ...
Dexcom receives FDA warning letter for 2 manufacturing sites
Dexcom, the local maker of continuous glucose monitors, received a warning letter from the Food and Drug Administration last ...
10 Best Diabetes Stocks To Buy According to Billionaires
The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...
Science Daily6d
New tech for managing type 1 diabetes is effective for older adults
New research suggests that automated insulin delivery (AID) systems are safe and effective for use by older adults with type 1 diabetes. The findings counter common assumptions that older adults would ...
Drug Delivery Business10d
Real-world data backs Insulet Omnipod 5 in children
A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young ...
Insulet Corporation: Insulet Expands Omnipod 5 to Four More International Markets
The Omnipod 5 Automated Insulin Delivery System is now commercially available in Australia, launching soon in Belgium, Canada, and Switzerland. Insulet Corporation (NASDAQ: PODD) (Insulet or the Compa ...
Continuous Glucose Monitoring Market To Hit USD 8.82 Billion By 2032 SNS Insider
Continuous Glucose Monitoring market poised for significant growth, driven by advancements in diabetes management and rising global prevalence.
CAR Magazine25d
Xpeng G6 (2025) review: is this X better than a Y?
This G6, from Chinese brand Xpeng, is the latest to launch – marking the start of the brand’s operations in the UK. We’ve already had a go in the new Xpeng G6 in Europe, but how does this ...